ClinVar Genomic variation as it relates to human health
NM_006494.4(ERF):c.1201_1202del (p.Lys401fs)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_006494.4(ERF):c.1201_1202del (p.Lys401fs)
Variation ID: 420168 Accession: VCV000420168.40
- Type and length
-
Deletion, 2 bp
- Location
-
Cytogenetic: 19q13.2 19: 42248910-42248911 (GRCh38) [ NCBI UCSC ] 19: 42753062-42753063 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Apr 27, 2017 Nov 17, 2024 Jan 12, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_006494.4:c.1201_1202del MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_006485.2:p.Lys401fs frameshift NM_006494.4:c.1201_1202delAA MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NM_001301035.2:c.976_977del NP_001287964.1:p.Lys326fs frameshift NM_001308402.2:c.976_977del NP_001295331.1:p.Lys326fs frameshift NM_001312656.2:c.976_977del NP_001299585.1:p.Lys326fs frameshift NM_006494.2:c.1201_1202del NM_006494.3:c.1201_1202delAA NC_000019.10:g.42248910_42248911del NC_000019.9:g.42753062_42753063del NG_042802.1:g.11254_11255del - Protein change
- K326fs, K401fs
- Other names
- -
- Canonical SPDI
- NC_000019.10:42248909:TT:
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD), exomes 0.00000
Trans-Omics for Precision Medicine (TOPMed) 0.00000
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
ERF | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
216 | 230 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (5) |
criteria provided, multiple submitters, no conflicts
|
Feb 10, 2022 | RCV000485362.30 | |
Pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
Jan 12, 2024 | RCV001263207.6 | |
Likely pathogenic (1) |
criteria provided, single submitter
|
Dec 22, 2020 | RCV001374966.3 | |
ERF-related disorder
|
Pathogenic (2) |
criteria provided, single submitter
|
Jun 23, 2023 | RCV003317236.4 |
Pathogenic (1) |
criteria provided, single submitter
|
Mar 26, 2021 | RCV001865446.8 | |
Pathogenic (1) |
criteria provided, single submitter
|
Jul 11, 2023 | RCV003313081.4 | |
Noonan Syndrome-like developmental disorder
|
Pathogenic (1) |
criteria provided, single submitter
|
Dec 31, 2023 | RCV004586731.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Jun 21, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Craniosynostosis 4
Affected status: yes
Allele origin:
de novo
|
Department of Medical Genetics, Oslo University Hospital
Accession: SCV001437568.1
First in ClinVar: Nov 06, 2020 Last updated: Nov 06, 2020 |
Number of individuals with the variant: 1
Clinical Features:
Craniosynostosis (present)
|
|
Pathogenic
(Oct 23, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
(Unknown mechanism)
Affected status: yes
Allele origin:
germline
|
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
Accession: SCV001447007.1
First in ClinVar: Nov 28, 2020 Last updated: Nov 28, 2020 |
Clinical Features:
Global developmental delay (present) , Abnormal facial shape (present) , Short stature (present)
Sex: female
|
|
Likely pathogenic
(Dec 22, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Neurodevelopmental disorder
Affected status: yes
Allele origin:
germline
|
Laboratory of Molecular Genetics (Pr. Bezieau's lab), CHU de Nantes
Accession: SCV001572254.1
First in ClinVar: Apr 28, 2021 Last updated: Apr 28, 2021 |
|
|
Pathogenic
(Feb 10, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000568838.6
First in ClinVar: Apr 27, 2017 Last updated: Mar 04, 2023 |
Comment:
Reported previously in the heterozygous state in multiple individuals with ERF-related clinical features referred for genetic testing at GeneDx and in the published literature (Twigg … (more)
Reported previously in the heterozygous state in multiple individuals with ERF-related clinical features referred for genetic testing at GeneDx and in the published literature (Twigg et al., 2013; Glass et al., 2019); Frameshift variant in the C-terminus predicted to result in protein truncation, as the last 148 amino acids are lost and replaced with 9 incorrect amino acids; Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 30758909, 23354439, 32370745) (less)
|
|
Pathogenic
(Jul 11, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Chitayat syndrome
Affected status: yes
Allele origin:
de novo
|
Department of Endocrinology and Genetics, Fuzhou Children’s Hospital of Fujian Medical University
Accession: SCV004012895.1
First in ClinVar: Jul 16, 2023 Last updated: Jul 16, 2023 |
Sex: male
|
|
Pathogenic
(Jun 23, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
ERF-Related Disorders
Affected status: unknown
Allele origin:
germline
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Accession: SCV004021048.1
First in ClinVar: Jul 29, 2023 Last updated: Jul 29, 2023 |
Comment:
Variant summary: ERF c.1201_1202delAA (p.Lys401GlufsX10) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein … (more)
Variant summary: ERF c.1201_1202delAA (p.Lys401GlufsX10) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 4.2e-06 in 236032 control chromosomes in gnomAD. c.1201_1202delAA has been reported in the literature in multiple individuals and families affected with ERF-Related Disorders (example: Twigg_2013, Korberg_2020, Glass_2019). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 30758909, 32370745, 23354439). Six submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. (less)
|
|
Pathogenic
(Dec 31, 2023)
|
criteria provided, single submitter
Method: research
|
Noonan Syndrome-like developmental disorder
Affected status: yes
Allele origin:
de novo
|
Tartaglia Lab, Genetics and Rare Diseases Research Division, Bambino Gesu' Children's Hospital
Accession: SCV004229155.1
First in ClinVar: Jul 15, 2024 Last updated: Jul 15, 2024 |
|
|
Pathogenic
(Jan 12, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Craniosynostosis 4
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
germline
|
Institute of Human Genetics, FAU Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg
Accession: SCV004231696.1
First in ClinVar: Jan 26, 2024 Last updated: Jan 26, 2024 |
Comment:
This variant has been identified by standard clinical testing. female patient with craniosynostosis and developmental disorder, inherited from affected father Selected ACMG criteria: Pathogenic (I):PP5;PS4;PVS1
Number of individuals with the variant: 2
|
|
Pathogenic
(Mar 26, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
TWIST1-related craniosynostosis
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV002217517.3
First in ClinVar: Mar 28, 2022 Last updated: Feb 20, 2024 |
Comment:
For these reasons, this variant has been classified as Pathogenic. This variant has been observed in individual(s) with craniosynostosis (PMID: 23354439, 30758909, 32370745). ClinVar contains … (more)
For these reasons, this variant has been classified as Pathogenic. This variant has been observed in individual(s) with craniosynostosis (PMID: 23354439, 30758909, 32370745). ClinVar contains an entry for this variant (Variation ID: 420168). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Lys401Glufs*10) in the ERF gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 148 amino acid(s) of the ERF protein. (less)
|
|
Pathogenic
(Dec 01, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV002063781.20
First in ClinVar: Jan 29, 2022 Last updated: Oct 20, 2024 |
Number of individuals with the variant: 1
|
|
Pathogenic
(Jul 21, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Craniosynostosis 4
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
germline
|
Pittsburgh Clinical Genomics Laboratory, University of Pittsburgh Medical Center
Accession: SCV005397446.1
First in ClinVar: Nov 17, 2024 Last updated: Nov 17, 2024 |
Comment:
This sequence variant is a two nucleotide deletion (delTT) in exon 4 of 4 of the ERF gene and results in an early termition codon … (more)
This sequence variant is a two nucleotide deletion (delTT) in exon 4 of 4 of the ERF gene and results in an early termition codon 10 amino acids downstream of the frameshift at Lys401. This variant is not predicted to result in nonsense mediated decay. However, early termitions downstream of this position have reported as pathogenic (ClinVar). This is a previously reported variant (ClinVar 420168) that has been observed in multiple individuals affected by craniosynostosis (PMID: 30758909, 32370745). This variant is de novo; however, it is present in the gnomAD population dataset (1 of 236032 alleles 0.0004%). Based upon the evidence, we consider this variant to be pathogenic. ACMG Criteria: PM2, PS2, PS4, PVS1 (less)
|
|
Likely pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001951889.1 First in ClinVar: Oct 02, 2021 Last updated: Oct 02, 2021 |
|
|
Pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001975199.1 First in ClinVar: Oct 08, 2021 Last updated: Oct 08, 2021 |
|
|
Pathogenic
(Aug 26, 2024)
|
no assertion criteria provided
Method: clinical testing
|
ERF-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV005361999.1
First in ClinVar: Oct 08, 2024 Last updated: Oct 08, 2024 |
Comment:
The ERF c.1201_1202delAA variant is predicted to result in a frameshift and premature protein termination (p.Lys401Glufs*10). This variant has been reported in individuals with syndromic … (more)
The ERF c.1201_1202delAA variant is predicted to result in a frameshift and premature protein termination (p.Lys401Glufs*10). This variant has been reported in individuals with syndromic craniosynostosis and in an individual with sagittal synostosis (Twigg et al. 2013. PubMed ID: 23354439; Glass et al. 2019. PubMed ID: 30758909; Körberg et al. 2020. PubMed ID: 32370745). This variant has also been reported in individuals with neurodevelopmental disorders and Noonan syndrome-like features (Table S1, Kaplanis et al. 2020. PubMed ID: 33057194; Dentici et al. 2024. PubMed ID: 38824261; Orsini et al. 2024. PubMed ID: 38674371). This variant has been reported de novo (Kaplanis et al. 2020. PubMed ID: 33057194; Dentici et al. 2024. PubMed ID: 38824261). This variant is reported in 0.00095% of alleles in individuals of European (Non-Finnish) descent in gnomAD and is reported as pathogenic/likely pathogenic in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/420168/). Frameshift variants in ERF are expected to be pathogenic. This variant is interpreted as pathogenic. (less)
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
A progressive and complex clinical course in two family members with ERF-related craniosynostosis: a case report. | Körberg I | BMC medical genetics | 2020 | PMID: 32370745 |
ERF-related craniosynostosis: The phenotypic and developmental profile of a new craniosynostosis syndrome. | Glass GE | American journal of medical genetics. Part A | 2019 | PMID: 30758909 |
Chitayat syndrome: hyperphalangism, characteristic facies, hallux valgus and bronchomalacia results from a recurrent c.266A>G p.(Tyr89Cys) variant in the ERF gene. | Balasubramanian M | Journal of medical genetics | 2017 | PMID: 27738187 |
Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis. | Twigg SR | Nature genetics | 2013 | PMID: 23354439 |
Text-mined citations for rs1064794325 ...
HelpRecord last updated Nov 19, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.